EQF
LEGN icon

Evergreen Quality Fund’s Legend Biotech LEGN Stock Holding History

Evergreen Quality Fund’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-81,400
Closed -$1.47M – 52
2026
Q1 		$1.47M Sell
81,400
-40,700
-33% -$776K 0.03% 38
2025
Q4 		$2.65M Sell
122,100
-192,400
-61% -$5.51M 0.05% 35
2025
Q3 		$10.3M Buy
314,500
+95,800
+44% +$3.54M 0.23% 28
2025
Q2 		$7.76M Buy
+218,700
New +$7.09M 0.24% 16

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Evergreen Quality Fund's LEGN Position: Q2 2026 in Review

Evergreen Quality Fund sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 81,400 shares — an estimated $1.47M sold.

Evergreen Quality Fund first reported a position in LEGN in Q2 2025 and held it in 4 quarters. The position peaked at $10.3M in Q3 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Evergreen Quality Fund reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Evergreen Quality Fund sold 81,400 Legend Biotech shares in Q2 2026, an estimated $1.47M.
  • Evergreen Quality Fund first reported a position in Legend Biotech in Q2 2025 and held it in 4 quarters.
  • Evergreen Quality Fund's Legend Biotech position peaked at $10.3M in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Evergreen Quality Fund's 13F filing for Q2 2026, filed 14 Aug 2026.